herp
simplex
viru
type
among
preval
human
pathogen
worldwid
neuroinvas
becom
latent
neuron
primari
infect
infect
individu
experi
sporad
viral
reactiv
shown
increas
risk
human
immunodefici
viru
type
sexual
acquisit
approxim
men
women
primari
infect
may
even
greater
effect
current
cure
vaccin
hsv
infect
antivir
medic
acyclovir
penciclovir
valacyclovir
proven
effect
approach
shorten
length
herp
reactiv
reduc
recur
outbreak
drug
specif
target
hsv
thymidin
kinas
tk
drugresist
mutant
aris
immunocompromis
eukaryot
cell
respond
environment
stress
stimuli
recruit
activ
signal
transduct
pathway
cjun
kinas
jnk
map
kinas
member
mitogenactiv
protein
kinas
mapk
famili
primarili
respons
stress
signal
proinflammatori
cytokin
stimul
activ
map
kinas
transmit
upstream
signal
downstream
factor
thu
mediat
cellular
apoptosi
differenti
growth
immun
jnk
map
kinas
also
report
stimul
mani
virus
virusassoci
protein
includ
varicellazost
viru
vzv
coxsackieviru
epsteinbarr
viru
ebv
sever
acut
respiratori
syndrom
sar
hepat
bc
viru
hbvhcv
activ
map
kinas
cascad
induc
virus
either
facilit
viral
lytic
cycl
serv
defens
mechan
host
cell
therefor
virusinduc
activ
map
kinas
pathway
consid
univers
import
viral
infect
cell
dynam
activ
map
kinas
activ
protein
caus
infect
studi
zacho
et
al
found
infect
activ
map
kinas
upstream
activ
mitogenactiv
protein
kinas
kinas
proteinerk
kinas
stimul
mclean
et
al
report
activ
viru
entri
immediateearli
ie
gene
express
correl
cjun
transactiv
activ
jnk
necessari
effici
karaca
et
al
indic
inhibit
map
kinas
activ
would
reduc
viral
propos
cellular
jnk
map
kinas
may
serv
potenti
target
prevent
viral
infect
pharmacolog
inhibitor
synthes
identifi
phosphoinositidedepend
inhibitor
potent
activ
block
research
demonstr
also
potent
rel
specif
inhibitor
tank
bind
kinas
kinas
inhibit
phosphoryl
nuclear
transloc
transcript
activ
interferon
regulatori
current
studi
report
exhibit
inhibitori
activ
infect
demonstr
antivir
activ
independ
activ
instead
mediat
disrupt
activ
map
kinas
pathway
best
knowledg
first
report
antivir
activ
studi
may
facilit
identif
new
antihsv
target
develop
therapeut
agent
rapamycin
pma
pyrrolidin
dithiocarbam
pdtc
obtain
beyotim
haimen
china
glo
lysi
buffer
luciferas
assay
kit
obtain
promega
biotechnolog
promega
bio
madison
usa
cytoplasm
nuclear
protein
extract
kit
bca
protein
assay
kit
purchas
thermo
scientif
pierc
rockford
usa
lipofectamin
transfect
reagent
trizol
reagent
dapi
alexa
fluor
goat
antimous
igg
hl
obtain
life
technolog
gaithersburg
usa
irdy
goatantirabbit
irdy
goatantimous
licor
block
buffer
obtain
licor
lincoln
usa
prostaglandin
antibodi
cjun
pcjun
gapdh
ripa
lysi
buffer
purchas
santa
cruz
biotechnolog
santa
cruz
usa
antibodi
akt
pakt
obtain
sunshinebio
nanj
china
antibodi
obtain
cell
signal
technolog
beverli
usa
recombin
human
obtain
r
system
minneapoli
usa
hela
vero
cell
obtain
american
type
cultur
collect
atcc
usa
infect
indic
cell
line
gener
vero
cell
stabli
transfect
g
promoterdriven
luciferas
report
plasmid
report
plasmid
clontech
california
usa
kindli
provid
dr
claushen
nagel
heinrich
pett
institut
leibniz
institut
experiment
virolog
obtain
sino
biolog
inc
beij
china
hf
g
propag
titrat
vero
cell
previous
titrat
also
perform
cell
detect
luciferas
activ
vitro
cytotox
measur
use
commerci
kit
dojindo
kumamoto
japan
via
colorimetr
method
accord
manufactur
instruct
briefli
cell
per
well
dispers
plate
cultur
h
serial
concentr
ad
triplic
h
cultur
reagent
dispens
well
plate
incub
h
absorb
nm
measur
use
tecan
infinit
micropl
reader
switzerland
cell
viabil
plot
percent
viabl
cell
mocktreat
control
cell
cell
lyse
use
ripa
lysi
buffer
ice
bath
min
lysat
centrifug
supernat
contain
total
protein
prepar
nuclear
cytoplasm
total
protein
separ
extract
use
commerci
kit
western
blot
perform
previous
incel
western
assay
conduct
accord
publish
briefli
cell
monolay
fix
paraformaldehyd
min
permeabil
wash
triton
pb
monolay
block
licor
block
buffer
incub
primari
antibodi
wash
pbst
buffer
cell
monolay
incub
irdy
igg
plate
rins
pbst
buffer
immedi
scan
licor
odyssey
infrar
imag
cell
seed
onto
mm
glass
coverslip
plate
densiti
cell
per
well
antibodi
stain
monolay
rins
pb
fix
paraformaldehyd
min
rt
permeabil
triton
min
follow
pb
wash
pb
contain
bsa
ad
well
block
nonspecif
bind
cellular
protein
immunolabel
respect
primari
antibodi
alexa
fluor
igg
nuclei
visual
stain
dapi
imag
acquir
use
olympu
fluoview
confoc
microscop
tokyo
japan
vero
cell
seed
plate
reach
confluenc
cell
transient
transfect
ng
luciferas
report
plasmid
alon
cotransfect
ng
luciferas
report
plasmid
ng
express
plasmid
cell
cultur
h
treat
inhibitor
luminesc
determin
use
micropl
luminomet
h
treatment
promega
madison
usa
titrat
follow
vero
cell
treat
absenc
presenc
serial
concentr
infect
g
h
cell
wash
twice
expos
complet
medium
frozen
thaw
three
cycl
releas
infecti
particl
viral
titrat
determin
use
luciferas
report
system
total
rna
extract
use
trizol
reagent
follow
manufactur
protocol
cdna
synthes
use
revertra
ace
qpcr
rt
kit
toyobo
osaka
japan
realtim
pcr
perform
triplic
abi
prism
sequenc
detect
system
use
sybr
green
pcr
master
mix
toyobo
accord
manufactur
protocol
primer
pair
use
studi
forward
revers
revers
gd
forward
revers
forward
revers
forward
revers
gd
forward
revers
gapdh
forward
revers
statist
analysi
perform
twotail
student
ttest
use
spss
softwar
spss
window
releas
spss
inc
statist
signific
p
p
initi
develop
inhibitor
molecular
structur
shown
figur
use
investig
effect
downstream
factor
replic
surprisingli
observ
exhibit
inhibitori
effect
cytopathogen
effect
cpe
data
shown
use
incel
western
assay
analyz
hsv
glycoprotein
gd
express
presenc
serial
concentr
cell
gd
protein
hsv
membran
protein
repres
late
event
viral
life
cycl
shown
figur
c
inhibit
hf
figur
g
figur
replic
cell
dosedepend
manner
inhibitori
activ
also
demonstr
vero
cell
shown
figur
e
inhibitori
activ
infect
also
investig
use
progeni
virion
releas
infect
vero
cell
infect
cell
shown
figur
prevent
format
infecti
particl
vero
cell
figur
cytotox
investig
two
cell
line
use
inhibitori
activ
analys
shown
figur
cell
remain
viabl
concentr
demonstr
appreci
therapeut
index
ti
suggest
viral
inhibitori
activ
due
cytotox
conclus
inhibit
replic
vero
cell
hsv
lytic
infect
involv
tempor
regul
express
three
class
viral
gene
ie
gene
earli
gene
late
ie
gene
express
first
follow
viral
entri
capsid
disassembl
regul
express
earli
late
viral
found
express
ie
gene
figur
figur
figur
significantli
inhibit
dosedepend
manner
measur
protein
level
h
postinfect
result
consist
decreas
gd
express
late
gene
product
regul
ie
gene
critic
format
infecti
virion
better
understand
effect
ie
gene
transcript
carri
realtim
pcr
analysi
mrna
express
h
postinfect
shown
figur
cell
pretreat
mrna
transcript
figur
figur
increas
dosedepend
manner
earli
stage
viral
infect
h
postinfect
effect
complex
h
pi
particularli
enhanc
effect
h
pi
contrast
h
postinfect
exhibit
inhibitori
effect
express
two
ie
gene
also
late
gene
gd
dosedepend
manner
base
observ
specul
reduc
hsv
ie
gene
express
directli
earli
period
viral
life
cycl
appar
inhibitori
activ
gd
mrna
level
h
postinfect
might
due
decreas
level
infecti
progeni
virion
presenc
identifi
potent
inhibitor
cellfre
system
investig
antivir
mechan
analyz
whether
act
inhibit
activ
first
investig
whether
hsv
infect
would
trigger
intracellular
pathway
western
blot
analysi
phosphorylatedakt
thu
induc
phosphoryl
akt
h
postinfect
suggest
viral
replic
infect
stimul
pathway
activ
figur
inhibit
phosphoryl
akt
h
postinfect
shown
figur
howev
pathway
activ
seem
requir
replic
due
fact
potent
inhibitor
rapamycin
mtor
inhibitor
fail
exhibit
effect
hsv
replic
shown
figur
gd
express
minim
affect
even
high
concentr
ngml
rapamycin
respect
inhibitor
use
suggest
pathway
regul
hsv
replic
rather
outcom
hsv
infect
therefor
seem
inhibit
replic
activ
investig
effect
treatment
pathway
pathway
two
major
stressactiv
inflammatori
respons
pathway
stimul
mani
viral
evid
shown
jnk
map
kinas
pathway
also
stimul
infect
activ
play
central
role
hsv
shown
figur
infect
increas
phosphoryl
jnk
reduc
erk
phosphoryl
h
postinfect
human
genit
epitheli
cell
cell
suggest
activ
jnk
mapk
pathway
similar
result
observ
data
shown
also
investig
whether
infect
would
influenc
phosphoryl
cjun
downstream
target
jnk
map
cjun
activ
h
postinfect
activ
phosphoryl
h
postinfect
shown
figur
elucid
pathway
crucial
replic
use
three
specif
mapk
inhibitor
inhibitor
jnk
inhibitor
erk
inhibitor
cell
result
figur
indic
inhibit
viral
replic
vero
cell
dosedepend
manner
suggest
jnk
pathway
ratelimit
step
hsv
viral
protein
synthesi
replic
consist
previou
found
interf
phosphoryl
activ
jnk
map
kinas
induc
infect
cell
h
postinfect
figur
furthermor
block
activ
cjun
figur
cjun
phosphoryl
activ
stimul
pma
figur
suggest
blockag
virusinduc
jnk
mapk
activ
specif
virusassoci
protein
rather
target
certain
cellular
kinas
associ
viral
infect
also
confirm
inhibit
cjun
nuclear
transloc
figur
induc
infect
pma
consist
result
shown
figur
also
found
inhibit
activ
dosedepend
manner
determin
luciferas
assay
figur
use
report
plasmid
whether
inhibit
activ
mediat
stimuli
investig
shown
figur
pma
sitedriven
luciferas
express
inhibit
confirm
effect
viral
replic
depend
investig
effect
overexpress
hsv
replic
inhibit
result
indic
compar
cell
viral
replic
increas
slightli
cell
overexpress
treatment
figur
result
indic
inhibit
hsv
replic
least
partial
rescu
overexpress
conclus
inhibit
hsv
replic
mediat
jnk
map
kinas
pathway
act
upstream
jnk
erk
respons
variou
environment
stress
mitogen
evid
shown
infect
lead
current
studi
investig
effect
infect
activ
cell
show
viral
infect
stimul
phosphoryl
gradual
reach
peak
h
postinfect
figur
complet
block
phosphoryl
figur
suggest
might
inhibit
map
kinas
activ
interf
phosphoryl
upstream
activ
import
herp
ie
protein
gener
potent
activ
viral
gene
express
report
stimul
intracellular
present
studi
evalu
effect
activ
shown
figur
imped
activ
vero
cell
howev
inhibit
activ
block
confirm
observ
diao
et
two
potent
inhibitor
pdtc
figur
block
activ
although
infect
caus
persist
activ
essenti
part
viral
although
observ
infect
led
degrad
figur
human
genit
tract
epitheli
cell
fail
inhibit
cytoplasm
degrad
h
postinfect
figur
contrast
potent
antiinflammatori
cyclopentenon
prostaglandin
inhibitor
inhibit
degrad
figur
transloc
assay
also
confirm
infect
induc
nuclear
transloc
block
figur
initi
develop
recent
also
report
potent
rel
specif
inhibitor
aurora
b
report
describ
novel
bioactiv
inhibit
replic
knowledg
report
describ
antivir
agent
adaptor
phosphatidylinositol
trisphosph
phosphoryl
form
phosphatidylinositol
bisphosph
catalyz
trigger
membran
coloc
akt
lead
downstream
mtor
hsu
et
al
report
infect
induc
activ
akt
pathway
oral
epitheli
cell
mediat
hsv
ie
gene
pyrimidin
nmoll
cellfre
also
activ
inhibit
akt
phosphoryl
activ
dosedepend
manner
shown
current
studi
figur
howev
result
specif
inhibitor
inhibitor
downstream
mtor
rapamycin
suggest
pathway
affect
viral
late
gene
express
replic
neither
molecul
inhibit
viral
late
gene
express
figur
although
activ
pathway
human
genit
tract
epitheli
cell
figur
shown
inhibit
attenu
gene
express
affect
thymidin
kinas
express
viral
replic
altern
explan
could
also
act
differ
target
rapamycin
pkc
downstream
factor
lead
activ
mediat
mapk
show
current
studi
inhibit
either
activ
figur
report
activ
affect
clark
et
al
also
found
affect
phosphoryl
degrad
induc
lp
poli
c
altogeth
result
suggest
antihsv
activ
independ
activ
jnk
map
kinas
pathway
import
hsv
gene
express
viral
mclean
et
al
report
activ
jnk
necessari
effici
hsv
replic
stabl
express
jnkinteract
protein
inhibitor
jnk
transloc
nucleu
led
reduct
karaca
et
al
found
presenc
cell
cultur
attenu
viru
find
consist
result
replic
cell
shown
figur
activ
map
kinas
may
stimul
viral
gene
transcript
via
downstream
activ
map
kinas
pathway
induc
infect
also
stimuli
pma
figur
demonstr
infect
induc
cjun
phosphoryl
bind
activ
figur
cjun
two
compon
transcript
factor
regul
gene
express
respons
varieti
stimuli
includ
cytokin
growth
factor
stress
two
protein
substrat
jnk
map
kinas
transcript
activ
cjun
regul
phosphoryl
target
jnk
map
kinas
signal
viral
replic
increas
cell
pretreat
overexpress
figur
indic
overexpress
partial
rescu
hsv
replic
inhibit
therefor
postul
inhibit
hsv
infect
attenu
activ
map
kinas
pathway
downstream
activ
hsv
protein
known
induc
map
kinas
pathway
zacho
et
al
demonstr
virion
transactiv
protein
necessari
suffici
activ
pathway
even
absenc
viral
howev
hargett
et
al
employ
hsv
ie
gene
mutant
virus
investig
viral
protein
necessari
map
kinas
activ
show
alon
although
controversi
exist
appar
viral
immediateearli
event
respons
map
kinas
activ
evid
suggest
activ
map
kinas
pathway
necessari
hsv
earli
late
gene
transcript
shown
figur
exhibit
inhibitori
effect
viral
transcript
h
postinfect
signific
inhibitori
effect
h
postinfect
therefor
postul
exert
antivir
activ
ie
late
gene
transcript
notabl
inhibit
downstream
map
kinas
activ
figur
howev
use
protein
kinas
assay
cellfre
system
clark
et
al
report
influenc
activ
discrep
clark
result
result
may
attribut
differ
experiment
system
use
cellfre
clark
cellbas
assay
although
less
like
higher
concentr
use
experi
anoth
potenti
explan
direct
target
map
kinas
pathway
may
upstream
report
shown
inhibit
could
act
upstream
activ
map
postul
inhibit
map
kinas
pathway
interf
upstream
howev
hypothesi
requir
investig
kinas
activ
ikk
direct
phosphoryl
play
vital
role
coordin
activ
innat
immun
member
interferon
regulatori
transcript
factor
pivot
ifn
product
innat
immun
respons
viral
ifn
known
inhibitori
effect
hsv
ie
earli
protein
et
report
hsv
infect
inhibit
activ
facilit
viral
product
infect
indic
neg
regul
hsv
propag
inhibit
nmoll
cellfre
system
respect
clear
whether
activ
contribut
antihsv
effici
therefor
effect
activ
hsv
infect
would
facilit
viral
replic
mani
virus
echoviru
procin
dengu
sar
encephalomyocard
vaccinia
also
report
activ
map
kinas
pathway
studi
shown
two
pathway
import
viral
identif
antihsv
activ
target
map
kinas
pathway
rais
possibl
may
also
possess
biolog
activ
virus
deserv
investig
airong
su
particip
design
studi
perform
statist
analysi
wrote
paper
min
qiu
particip
design
studi
help
draft
manuscript
yanlei
li
design
perform
analyz
experi
shown
figur
wentao
xu
design
perform
analyz
experi
shown
figur
siwei
song
design
perform
analyz
experi
shown
figur
xiaohui
wang
hongyong
song
design
perform
analyz
experi
shown
figur
nan
zheng
help
conceiv
coordin
studi
provid
technic
assist
contribut
prepar
figur
zhiwei
wu
conceiv
supervis
studi
revis
paper
first
three
author
contribut
equal
author
review
result
approv
final
version
manuscript
